help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nordenskjöld, A.
Right arrow Articles by Ivarsson, S.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nordenskjöld, A.
Right arrow Articles by Ivarsson, S.-A.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 9 3236-3238
Copyright © 1998 by The Endocrine Society


Original Studies

Molecular Characterization of 5{alpha}-Reductase Type 2 Deficiency and Fertility in a Swedish Family1

Agneta Nordenskjöld and Sten-Anders Ivarsson

Department of Molecular Medicine, Clinical Genetics Unit and Pediatric Surgery (A.N.), Karolinska Hospital/St. Görans Hospital, Stockholm; and Department of Pediatrics (S.-A.I.), University of Lund, University Hospital, Malmö, Sweden

Address all correspondence and requests for reprints to: A. Nordenskjöld, Department of Molecular Medicine, CMM 02, Karolinska Hospital, S-171 76 Stockholm, Sweden. E-mail: agneta.nordenskjold{at}cmm.ki.se


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
The molecular background of 5{alpha}-reductase type 2 deficiency was investigated in a Swedish family with no known consanguinity and in which the affected males were fertile. The three male siblings were born with ambiguous external genitalia, and the diagnosis of 5{alpha}-reductase deficiency was established at the ages of 16, 14, and 10 yr, respectively. All three siblings underwent surgery for hypospadias repair. At least two of the brothers are demonstrably fertile. Molecular analysis showed the three brothers to be compound heterozygotes, carrying two different mutations in exon 4 of the 5{alpha}-reductase type 2 gene. The two mutations (G196S and H231R) have been described previously and reported to give rise to partially functioning enzymes, which may explain the milder phenotype and perhaps the fertility in the preset three patients.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
TESTOSTERONE 5{alpha}-reductase type 2 converts testosterone to dihydrotestosterone and is crucial for the development of male external genital organs including the prostate gland (1). The rare form of male pseudohermaphroditism caused by 5{alpha}-reductase type 2 enzyme deficiency is inherited in an autosomal recessive fashion. Neonates with deficiency of this enzyme are usually assigned female gender at birth and raised as girls, although they are 46,XY individuals with bilateral testes and male wolffian duct structures. A predominant characteristic of the disorder is the spontaneous virilization, both physically and psychologically, that occurs during puberty because of the effects of testosterone itself (or of dihydrotestosterone formed by the mutant enzyme) or to an increased activity of the isoenzyme (5{alpha}-reductase type 1) or a combination of both of these (2, 3, 4). Over 30 different mutations variously localized over the gene have been described (5, 6, 7, 8, 9, 10). The majority of these are missense or nonsense mutations, giving rise to a nonfunctional or subfunctional protein (11). Deletions have been described in five families (1, 7, 10, 12). The clinical spectrum arising from this deficiency ranges from a male phenotype with hypospadias to a female phenotype with normal wolffian structures (10). Of the mutations described to date, 60% are homozygous and 40% are associated with documented consanguinity (1). Here we report the molecular basis of a previously reported Swedish 5{alpha}-reductase type 2-deficient family with male siblings operated on for hypospadias (13), of whom two are the first cases of proven fertility to have been reported (14).


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
Patients

The patients were three siblings born with ambiguous genitalia and normal male karyotype, 46,XY (13). They all manifested severe hypospadias, microphallus, well-developed scrotum, and cryptorchidism. The 5{alpha}-reductase deficiency was diagnosed after biochemical analysis at the ages of 16, 14, and 10 yr, respectively. The boys had no axillary hair, no temporal recession of the hairline, and no gynecomastia. The phallus sizes when they were diagnosed were 4.5, 2.5, and 1.3 cm, respectively. Dihydrotestosterone levels were low (0.67 nmol/L in one boy and not measurable in the other two boys; normal, 0.76–3.0 nmol/L) and testosterone levels were high (31.0, 9.4, and 1.2 nmol/L, respectively; normal, 0–3.5 nmol/L in children and 6–30 nmol/L in adults), especially in the oldest boy who had reached puberty. All three brothers were operated on several times for hypospadias and cryptorchidism. There is no known consanguinity in the family. Two of the brothers each have a child, and paternity has been verified (14).

Mutation screening

Constitutional DNA was prepared from the family members according to routine protocols. PCR products generated by exon flanking primers according to the published sequence of the SRD5A2 gene (15) were screened for mutations using a combination of denaturing gradient gel electrophoresis (DGGE) (exons 2 and 4) and single-stranded conformational polymorphism (exons 1, 3, and 5). Fragments manifesting divergent migration were sequenced. Details are available on request.


    Results and Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
Screening for mutations in exons 1–3 and 5 failed to show any aberrant bands. DGGE of exon 4 yielded four abnormal bands indicating two different mutations. DNA sequencing confirmed this and showed these individuals to be compound heterozygotes with mutations in codons 196 and 231. The mutation in codon 231 was a change from CAC (histidine) to CGC (arginine) (H231R) (Fig. 1AGo, middle sequence). DNA sequence analysis also showed a mutation in codon 196 that resulted in a change from GGT (glycine) to AGT (serine) (G196S) (Fig. 1BGo, middle sequence). Further studies of the individuals in this family showed that the G196S mutation was inherited from the mother and the H231R mutation from the father (Fig. 1Go). The results of the DGGE screening in the whole family are shown in Fig. 2Go. The two grandchildren each inherited the H231R mutation in heterozygous form from their grandfather.



View larger version (65K):
[in this window]
[in a new window]
 
Figure 1. A, DNA sequence analysis of exon 4 in one of the affected boys flanked by his parents. A heterozygous mutation in codon 231 in the males resulting in a change from CAC (histidine) to CGC (arginine) is shown. B, DNA sequence analysis showing a heterozygous mutation in codon 196 in one of the affected boys and his mother that arose after a change from GGT (glycine) to AGT (serine).

 


View larger version (50K):
[in this window]
[in a new window]
 
Figure 2. DGGE analysis of the whole family, with pedigree shown above. An arrow marks wt homoduplex band.

 
The mutations detected in this study were described previously as occurring either in a homozygous form or in a presumed compound heterozygous form. Three patients with G196S mutation in homozygous form have been described, one in a Greek-American family and two in Turkish families (1, 10). All these patients had a male phenotype. In the two Turkish families there was known consanguinity.

The H231R mutation in a homozygous form has previously been described in three separate cases from different ethnic groups: Polish, Italian, and German. These cases were all considered to be girls at birth (6, 8, 10). The mutation has even been reported in a heterozygous form in two cases regarded as presumed compound heterozygotes, one in an Afro-American and the other in an American Caucasian proband (1). The American Caucasian patient had ambiguous genitalia from birth and was assigned to be female and the gonads were removed (5).

Most men with 5{alpha}-reductase deficiency are infertile because of a number of factors. Deficiency of dihydrotestosterone results in a low volume ejaculate of high viscosity. Many have azospermia or oligospermia associated with undescended testes and complications of genitourinary surgery. Early correction of cryptorchidism and hypospadias is crucial to prevent damage to the seminiferous tubules and to preserve spermatogenesis and future fertility.

Even in affected men with adequate spermatogenesis who have undergone surgical correction of the genitalia, the characteristic very low semen volume and increased viscosity can reduce fertility (9, 16). Whether this abnormality is a direct effect of the mutation or a secondary consequence of incomplete testicular descent is uncertain. Recently, one couple in which the male had 5{alpha}-reductase deficiency and a low semen volume successfully became parents after intrauterine insemination of his sperm (17).

As mentioned above, G196S (homozygosity) produces a predominantly male phenotype, and in all of these children that have been reported, the phallus is so large that they are identified as males with hypospadias and raised as boys. Comparison of the phenotypes with this mutation show a correlation to exist between the mutation and the phenotype of a given subject.

Biochemical analysis suggested a correlation existed between clinical expression and severity of the impairment of enzyme function. Eight mutations including G196S decreased the affinity of the type 2 isoenzyme for nicotinamide adenine dinucleotide phosphate (NADPH) (11). The other mutation in our patients (i.e. H231R) primarily affected the ability of the enzyme to bind testosterone (11). The H231R mutant protein possesses about 15% of the activity of the normal enzyme and the G196S mutant protein 10% when they are expressed in cultured cells (11). This may be an alternative explanation of the masculinization and perhaps the fertility of our patients, because the majority of missense mutations in the steroid 5{alpha}-reductase 2 gene are associated with <0.4% of normal enzyme activity (11).

The H231R mutation has been found in individuals of widely differing geographical and ethnic backgrounds, suggesting that this sequence in exon 4 is a mutational hot spot. The finding that almost half of the subjects are known or presumed compound heterozygotes suggests that the carrier frequency of mutations in the type 2 gene maybe quite high, and thus that the putative mutational hot spots in the gene might result in an increased carrier frequency. Alternatively, there may be an as yet unidentified selective advantage to being a heterozygous carrier.

The diagnosis of 5{alpha}-reductase deficiency must be taken into consideration in the differential diagnosis of boys with hypospadias (at least familial hypospadias), especially in cases with cryptorchidism and/or a small phallus. It is important that the diagnosis be made in infancy by means of biochemical and molecular techniques, because these patients should be considered to be boys from birth.


    Acknowledgments
 
We express our sincere gratitude to the family participating in this study. We wish to thank Margareta Tapper-Persson for excellent technical assistance.


    Footnotes
 
1 This work was supported by the HRH Crown Princess Lovisa Foundation, the Wera Ekström Fund, the Åke Wiberg Fund, Märta and Gunnar Philipsson Foundation, and Karolinska Institute. Back

Received November 17, 1997.

Revised June 2, 1998.

Accepted June 9, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Wilson JD, Griffin JE, Russell DW. 1993 Steroid 5{alpha}-reductase 2 deficiency. Endocr Rev. 14:577–593.[Abstract/Free Full Text]
  2. Imperato-McGinley J, Guerrero L, Gautier T, Peterson R. 1974 Steroid 5{alpha}-reductase 2 deficiency in man: an inherited form of male pseudohermaphroditism. Science. 186:1213–1215.[Abstract/Free Full Text]
  3. Peterson RE, Imperato-McGinley J, Gautier T, Sturla E. 1977 Male pseudohermaphroditism due to steroid 5{alpha}- reductase deficiency. Am J Med. 62: 170–191.
  4. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. 1979 Male pseudohermaphroditism secondary to 5{alpha}-reductase deficiency—a model for the role of androgens in both the development of the male phenotype and the evolution of male gender identity. J Steroid Biochem. 11:637–645.[CrossRef][Medline]
  5. Thigpen AE, Davis DL, Milatovich A, et al. 1992 Molecular genetics of steroid 5{alpha}-reductase 2 deficiency. J Clin Invest. 90:799–809.
  6. Boudon C, Lumbroso S, Lobaccaro JM, et al. 1995 Molecular study of the 5{alpha}-reductase type 2 gene in three European families with 5{alpha}-reductase deficiency. J Clin Endocrinol Metab. 80:2149–2153.[Abstract]
  7. Boudon C, Lobaccaro JM, Lumbroso S, et al. 1995 A new deletion of the 5{alpha}-reductase type 2 gene in a Turkish family with 5{alpha}-reductase deficiency. Clin Endocrinol (Oxf). 43:183–188.[Medline]
  8. Forti G, Falchetti A, Santoro S, Davis DL, Wilson JD, Russell DW. 1996 Steroid 5{alpha}-reductase 2 deficiency: virilization in early infancy may be due to partial function of mutant enzyme. Clin Endocrinol (Oxf). 44:477–482.[CrossRef][Medline]
  9. Mendonca BB, Inacio M, Costa EMF, et al. 1996 Male pseudohermaphroditism due to steroid 5{alpha}-reductase deficiency. Medicine. 75:64–76.[CrossRef][Medline]
  10. Sinnecker GHG, Hiort O, Dibbelt L, et al. 1996 Phenotypic classification of male pseudohermaphroditism due to steroid 5{alpha}-reductase deficiency. Am J Med Genet. 63:223–230.[CrossRef][Medline]
  11. Wigley WC, Prihoda JS, Mowszowicz I, et al. 1994 Natural mutagenesis study of the human steroid 5{alpha}-reductase 2 isoenzyme. Biochemistry. 33:1265–1270.[CrossRef][Medline]
  12. Andersson S, Berman DM, Jenkins EP, Russell DW. 1991 Deletion of steroid 5{alpha}-reductase 2 gene in male pseudohermaphroditism. Nature. 354:159–161.[CrossRef][Medline]
  13. Ivarsson SA, Damkjaer-Nielsen M, Lindberg T. 1988 Male pseudohermaphroditism due to 5{alpha}-reductase deficiency in a Swedish family. Eur J Pediatr. 147:532–535.[CrossRef][Medline]
  14. Ivarsson SA. 1996 5{alpha}-reductase deficient men are fertile. Eur J Pediatr. 155:425.
  15. Labrie F, Sugimoto Y, Luu-The V, et al. 1992 Structure of human type II 5{alpha}-reductase gene. Endocrinology. 131:1571–1573.[Abstract/Free Full Text]
  16. Cai LQ, Fratianni CM, Gautier T, Imperato-McGinley J. 1994 Dihydrotestosterone regulation of semen in male pseudohermaphroditism with 5{alpha}-reductase deficiency. J Clin Endocrinol Metab. 79:409–414.[Abstract]
  17. Katz MD, Kligman I, Cai LQ, et al. 1997 Paternity by intrauterine insemination with sperm from a man with 5{alpha}- reductase-2 deficiency. N Engl J Med. 336:994–997.[Free Full Text]



This article has been cited by other articles:


Home page
J AndrolHome page
F. Baldinotti, S. Majore, A. Fogli, G. Marrocco, P. Ghirri, M. Vuerich, S. Tumini, B. Boscherini, M. Vetri, S. Scommegna, et al.
Molecular Characterization of 6 Unrelated Italian Patients With 5{alpha}-Reductase Type 2 Deficiency
J Androl, January 1, 2008; 29(1): 20 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. T. T. Thai, M. Kalbasi, K. Lagerstedt, L. Frisen, I. Kockum, and A. Nordenskjold
The Valine Allele of the V89L Polymorphism in the 5-{alpha}-Reductase Gene Confers a Reduced Risk for Hypospadias
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6695 - 6698.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
M. Fernandez-Cancio, M. Nistal, R. Gracia, M. A. Molina, J. A. Tovar, C. Esteban, A. Carrascosa, and L. Audi
Compound Heterozygous Mutations in the SRD5A2 Gene Exon 4 in a Male Pseudohermaphrodite Patient of Chinese Origin
J Androl, May 1, 2004; 25(3): 412 - 416.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nordenskjöld, A.
Right arrow Articles by Ivarsson, S.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nordenskjöld, A.
Right arrow Articles by Ivarsson, S.-A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals